{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:15:54Z","timestamp":1792631754932,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:00:00Z","timestamp":1485475200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400418"],"award-info":[{"award-number":["81400418"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00417-017-3599-8","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T16:10:36Z","timestamp":1485533436000},"page":"639-649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis"],"prefix":"10.1007","volume":"255","author":[{"given":"Ping","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"3599_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1088\/0967-3334\/32\/5\/002","volume":"32","author":"PH Tsui","year":"2011","unstructured":"Tsui PH, Huang CC, Zhou Q, Shung KK (2011) Cataract measurement by estimating the ultrasonic statistical parameter using an ultrasound needle transducer: an in vitro study. Physiol Meas 32:513\u2013522. doi: 10.1088\/0967-3334\/32\/5\/002","journal-title":"Physiol Meas"},{"key":"3599_CR2","first-page":"207","volume":"9","author":"R Isaacs","year":"2004","unstructured":"Isaacs R, Ram J, Apple D (2004) Cataract blindness in the developing world: is there a solution? J Agromedicine 9:207\u2013220","journal-title":"J Agromedicine"},{"key":"3599_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1442-9071.2009.02084.x","volume":"37","author":"DS Lam","year":"2009","unstructured":"Lam DS, Li EY, Chang DF, Zhang MZ, Zhan HK, Pang CP (2009) Project vision: a new and sustainable model for eliminating cataract blindness in China. Clin Exp Ophthalmol 37:427\u2013430. doi: 10.1111\/j.1442-9071.2009.02084.x","journal-title":"Clin Exp Ophthalmol"},{"key":"3599_CR4","doi-asserted-by":"publisher","first-page":"e60236","DOI":"10.1371\/journal.pone.0060236","volume":"8","author":"W Shen","year":"2013","unstructured":"Shen W, Yang Y, Yu M, Li J, Wei T, Li X, Li J, Su X, Zhong H, Yuan Y (2013) Prevalence and outcomes of cataract surgery in adult rural Chinese populations of the Bai nationality in Dali: the Yunnan minority eye study. PLoS One 8:e60236. doi: 10.1371\/journal.pone.0060236","journal-title":"PLoS One"},{"key":"3599_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/ICU.0b013e3283436fc5","volume":"22","author":"S Rofagha","year":"2011","unstructured":"Rofagha S, Bhisitkul RB (2011) Management of retained lens fragments in complicated cataract surgery. Curr Opin Ophthalmol 22:137\u2013140. doi: 10.1097\/ICU.0b013e3283436fc5","journal-title":"Curr Opin Ophthalmol"},{"key":"3599_CR6","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2147\/OPTH.S38303","volume":"6","author":"HM Jammal","year":"2012","unstructured":"Jammal HM, Khader Y, Shawer R, Al Bdour M (2012) Posterior segment causes of reduced visual acuity after phacoemulsification in eyes with cataract and obscured fundus view. Clin Ophthalmol 6:1843\u20131848. doi: 10.2147\/OPTH.S38303","journal-title":"Clin Ophthalmol"},{"key":"3599_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1159\/000377635","volume":"53","author":"D Melancia","year":"2015","unstructured":"Melancia D, Abeg\u00e3o Pinto L, Marques-Neves C (2015) Cataract surgery and intraocular pressure. Ophthal Res 53:141\u2013148. doi: 10.1159\/000377635","journal-title":"Ophthal Res"},{"key":"3599_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/OPTH.S1439","volume":"2","author":"T Higashide","year":"2008","unstructured":"Higashide T, Sugiyama K (2008) Use of viscoelastic substance in ophthalmic surgery - focus on sodium hyaluronate. Clin Ophthalmol 2:21\u201330","journal-title":"Clin Ophthalmol"},{"key":"3599_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/jop.2010.0135","volume":"27","author":"LD Waterbury","year":"2011","unstructured":"Waterbury LD, Galindo D, Villanueva L, Nguyen C, Patel M, Borbridge L, Attar M, Schiffman RM, Hollander DA (2011) Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation. J Ocul Pharmacol Ther 27:173\u2013178. doi: 10.1089\/jop.2010.0135","journal-title":"J Ocul Pharmacol Ther"},{"key":"3599_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/protein\/gzp058","volume":"22","author":"KH Ruan","year":"2009","unstructured":"Ruan KH, Cervantes V, So SP (2009) Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2. Protein Eng Des Sel 22:733\u2013740. doi: 10.1093\/protein\/gzp058","journal-title":"Protein Eng Des Sel"},{"key":"3599_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/00055735-199808000-00007","volume":"9","author":"J Nichols","year":"1998","unstructured":"Nichols J, Snyder RW (1998) Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr Opin Ophthalmol 9:40\u201344. doi: 10.1097\/00055735-199808000-00007","journal-title":"Curr Opin Ophthalmol"},{"key":"3599_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/ICU.0b013e3282f03d2e","volume":"18","author":"A Rothova","year":"2007","unstructured":"Rothova A (2007) Inflammatory cystoid macular edema. Curr Opin Ophthalmol 18:487\u2013492. doi: 10.1097\/ICU.0b013e3282f03d2e","journal-title":"Curr Opin Ophthalmol"},{"key":"3599_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/bjo.2005.073817","volume":"89","author":"S Sivaprasad","year":"2005","unstructured":"Sivaprasad S, Bunce C, Wormald R (2005) Non-steroidal anti-inflammatory agents for cystoid macular oedema following cataract surgery: a systematic review. Br J Ophthalmol 89:1420\u20131422. doi: 10.1136\/bjo.2005.073817","journal-title":"Br J Ophthalmol"},{"key":"3599_CR14","doi-asserted-by":"publisher","unstructured":"Sivaprasad S, Bunce C, Crosby-Nwaobi R (2012) Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev CD004239. doi: 10.1002\/14651858.CD004239.pub3","DOI":"10.1002\/14651858.CD004239.pub3"},{"key":"3599_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/eye.2011.296","volume":"26","author":"T Yilmaz","year":"2012","unstructured":"Yilmaz T, Cordero-Coma M, Gallagher MJ (2012) Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review. Eye (Lond) 26:252\u2013258. doi: 10.1038\/eye.2011.296","journal-title":"Eye (Lond)"},{"key":"3599_CR16","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.ophtha.2015.05.014","volume":"122","author":"SJ Kim","year":"2015","unstructured":"Kim SJ, Schoenberger SD, Thorne JE, Ehlers JP, Yeh S, Bakri SJ (2015) Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology. Ophthalmology 122:2159\u20132168. doi: 10.1016\/j.ophtha.2015.05.014","journal-title":"Ophthalmology"},{"key":"3599_CR17","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. doi: 10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"3599_CR18","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group, Cochrane Statistical Methods Group (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. doi: 10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"3599_CR19","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","volume":"66","author":"J Andrews","year":"2013","unstructured":"Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, Nasser M, Meerpohl J, Post PN, Kunz R, Brozek J, Vist G, Rind D, Akl EA, Sch\u00fcnemann HJ (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66:719\u2013725. doi: 10.1016\/j.jclinepi.2012.03.013","journal-title":"J Clin Epidemiol"},{"key":"3599_CR20","doi-asserted-by":"publisher","first-page":"i1777","DOI":"10.1136\/bmj.i1777","volume":"353","author":"GS Hazlewood","year":"2016","unstructured":"Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C (2016) Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ 353:i1777. doi: 10.1136\/bmj.i1777","journal-title":"BMJ"},{"key":"3599_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jrsm.1045","volume":"3","author":"IR White","year":"2012","unstructured":"White IR, Barrett JK, Jackson D, Higgins JP (2012) Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 3:111\u2013125. doi: 10.1002\/jrsm.1045","journal-title":"Res Synth Methods"},{"key":"3599_CR22","doi-asserted-by":"publisher","first-page":"e0145066","DOI":"10.1371\/journal.pone.0145066","volume":"10","author":"D Li","year":"2015","unstructured":"Li D, Wang T, Shen S, Cheng S, Yu J, Zhang Y, Zhang C, Tang H (2015) Effects of fluroquinolones in newly diagnosed, sputum-positive tuberculosis therapy: a systematic review and network meta-analysis. PLoS One 10:e0145066. doi: 10.1371\/journal.pone.0145066","journal-title":"PLoS One"},{"key":"3599_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2288-12-150","volume":"12","author":"L Trinquart","year":"2012","unstructured":"Trinquart L, Chatellier G, Ravaud P (2012) Adjustment for reporting bias in network meta-analysis of antidepressant trials. BMC Med Res Methodol 12:150. doi: 10.1186\/1471-2288-12-150","journal-title":"BMC Med Res Methodol"},{"key":"3599_CR24","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1016\/j.jcrs.2015.10.053","volume":"41","author":"JA Hovanesian","year":"2015","unstructured":"Hovanesian JA, Sheppard JD, Trattler WB, Gayton JL, Malhotra RP, Schaaf DT, Ng E, Dunn SH (2015) Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: integrated results from 2 pivotal phase 3 studies. J Cataract Refract Surg 41:2060\u20132068. doi: 10.1016\/j.jcrs.2015.10.053","journal-title":"J Cataract Refract Surg"},{"key":"3599_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jcrs.2013.07.042","volume":"40","author":"SS Modi","year":"2014","unstructured":"Modi SS, Lehmann RP, Walters TR, Fong R, Christie WC, Roel L, Nethery D, Sager D, Tsorbatzoglou A, Philipson B, Traverso CE, Reiser H (2014) Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study. J Cataract Refract Surg 40:203\u2013211. doi: 10.1016\/j.jcrs.2013.07.042","journal-title":"J Cataract Refract Surg"},{"key":"3599_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ophtha.2013.07.006","volume":"121","author":"TR Walters","year":"2014","unstructured":"Walters TR, Goldberg DF, Peace JH, Gow JA, Bromfenac Ophthalmic Solution 0.07% Once Daily Study Group (2014) Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials. Ophthalmology 121:25\u201333. doi: 10.1016\/j.ophtha.2013.07.006","journal-title":"Ophthalmology"},{"key":"3599_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12348-011-0036-8","volume":"1","author":"J Numaga","year":"2011","unstructured":"Numaga J (2011) Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients. J Ophthal Inflamm Infect 1:147\u2013155. doi: 10.1007\/s12348-011-0036-8","journal-title":"J Ophthal Inflamm Infect"},{"key":"3599_CR28","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.ophtha.2011.04.035","volume":"118","author":"BA Henderson","year":"2011","unstructured":"Henderson BA, Gayton JL, Chandler SP, Gow JA, Klier SM, McNamara TR, Bromfenac Ophthalmic Solution (Bromday) Once Daily Study Group (2011) Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain. Ophthalmology 118:2120\u20132127. doi: 10.1016\/j.ophtha.2011.04.035","journal-title":"Ophthalmology"},{"key":"3599_CR29","doi-asserted-by":"publisher","first-page":"420.e1","DOI":"10.1016\/j.ajo.2010.09.003","volume":"151","author":"ED Donnenfeld","year":"2011","unstructured":"Donnenfeld ED, Nichamin LD, Hardten DR, Raizman MB, Trattler W, Rajpal RK, Alpern LM, Felix C, Bradford RR, Villanueva L, Hollander DA, Schiffman RM (2011) Twice-daily, preservative-free ketorolac 0.45% for treatment of inflammation and pain after cataract surgery. Am J Ophthalmol 151:420.e1\u2013426.e1. doi: 10.1016\/j.ajo.2010.09.003","journal-title":"Am J Ophthalmol"},{"key":"3599_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/jop.2008.0023","volume":"24","author":"WA Maxwell","year":"2008","unstructured":"Maxwell WA, Reiser HJ, Stewart RH, Cavanagh HD, Walters TR, Sager DP, Meuse PA (2008) Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery. J Ocul Pharmacol Ther 24:593\u2013599. doi: 10.1089\/jop.2008.0023","journal-title":"J Ocul Pharmacol Ther"},{"key":"3599_CR31","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/jop.2007.0040","volume":"23","author":"RH Stewart","year":"2007","unstructured":"Stewart RH, Grillone LR, Shiffman ML, Donnenfeld ED, Gow JA, Bromfenac Ophthalmic Solution 0.09% Study Group (2007) The systemic safety of bromfenac ophthalmic solution 0.09%. J Ocul Pharmacol Ther 23:601\u2013612. doi: 10.1089\/jop.2007.0040","journal-title":"J Ocul Pharmacol Ther"},{"key":"3599_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcrs.2006.08.043","volume":"33","author":"SS Lane","year":"2007","unstructured":"Lane SS, Modi SS, Lehmann RP, Holland EJ (2007) Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. J Cataract Refract Surg 33:53\u201358. doi: 10.1016\/j.jcrs.2006.08.043","journal-title":"J Cataract Refract Surg"},{"key":"3599_CR33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/112067210301300605","volume":"13","author":"B Scuderi","year":"2003","unstructured":"Scuderi B, Driussi GB, Chizzolini M, Salvetat ML, Beltrame G (2003) Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery. Eur J Ophthalmol 13:536\u2013540","journal-title":"Eur J Ophthalmol"},{"key":"3599_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0161-6420(00)00543-1","volume":"108","author":"KD Solomon","year":"2001","unstructured":"Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A (2001) Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108:331\u2013337. doi: 10.1016\/S0161-6420(00)00543-1","journal-title":"Ophthalmology"},{"key":"3599_CR35","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0149-2918(00)88323-X","volume":"21","author":"R Stewart","year":"1999","unstructured":"Stewart R, Grosserode R, Cheetham JK, Rosenthal A (1999) Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. Clin Ther 21:723\u2013732. doi: 10.1016\/S0149-2918(00)88323-X","journal-title":"Clin Ther"},{"key":"3599_CR36","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0002-9394(98)00413-9","volume":"127","author":"J Heier","year":"1999","unstructured":"Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A (1999) Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial. Am J Ophthalmol 127:253\u2013259. doi: 10.1016\/S0002-9394(98)00413-9","journal-title":"Am J Ophthalmol"},{"key":"3599_CR37","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0161-6420(98)99053-4","volume":"105","author":"AJ Flach","year":"1998","unstructured":"Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA (1998) Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Ophthalmology 105:1775\u20131779. doi: 10.1016\/S0161-6420(98)99053-4","journal-title":"Ophthalmology"},{"key":"3599_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1034\/j.1600-0420.1998.760318.x","volume":"76","author":"I Ko\u00e7ak","year":"1998","unstructured":"Ko\u00e7ak I, Yalva\u00e7 IS, Ko\u00e7ak A, Nur\u00f6zler A, Unl\u00fc N, Kasim R, Duman S (1998) Comparison of the anti-inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extraction. Acta Ophthalmol Scand 76:343\u2013345. doi: 10.1034\/j.1600-0420.1998.760318.x","journal-title":"Acta Ophthalmol Scand"},{"issue":"Suppl 1","key":"3599_CR39","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0886-3350(96)80163-5","volume":"22","author":"M Diestelhorst","year":"1996","unstructured":"Diestelhorst M, Schmidl B, Konen W, Mester U, Raj PS (1996) Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation. J Cataract Refract Surg 22(Suppl 1):788\u2013793. doi: 10.1016\/S0886-3350(96)80163-5","journal-title":"J Cataract Refract Surg"},{"key":"3599_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0886-3350(13)80611-6","volume":"19","author":"JE Blaydes Jr","year":"1993","unstructured":"Blaydes JE Jr, Kelley EP, Walt JG, DeGryse RE, Harper DG, Novack GD (1993) Flurbiprofen 0.03% for the control of inflammation following cataract extraction by phacoemulsification. J Cataract Refract Surg 19:481\u2013487. doi: 10.1016\/S0886-3350(13)80611-6","journal-title":"J Cataract Refract Surg"},{"key":"3599_CR41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0886-3350(13)80153-8","volume":"20","author":"MC Kraff","year":"1994","unstructured":"Kraff MC, Martin RG, Neumann AC, Weinstein AJ (1994) Efficacy of diclofenac sodium ophthalmic solution versus placebo in reducing inflammation following cataract extraction and posterior chamber lens implantation. J Cataract Refract Surg 20:138\u2013144. doi: 10.1016\/S0886-3350(13)80153-8","journal-title":"J Cataract Refract Surg"},{"key":"3599_CR42","first-page":"873","volume":"18","author":"D Sabiston","year":"1987","unstructured":"Sabiston D, Tessler H, Sumers K, Osterle C, Cheetham JK, Duzman E, DeGryse R (1987) Reduction of inflammation following cataract surgery by the nonsteroidal anti-inflammatory drug, flurbiprofen. Ophthal Surg 18:873\u2013877","journal-title":"Ophthal Surg"},{"key":"3599_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0924-8579(99)00159-4","volume":"14","author":"SG Dastidar","year":"2000","unstructured":"Dastidar SG, Ganguly K, Chaudhuri K, Chakrabarty AN (2000) The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents 14:249\u2013251. doi: 10.1016\/S0924-8579(99)00159-4","journal-title":"Int J Antimicrob Agents"},{"key":"3599_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1100\/tsw.2002.81","volume":"2","author":"CN Serhan","year":"2002","unstructured":"Serhan CN, Chiang N (2002) Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. ScientificWorldJournal 2:169\u2013204. doi: 10.1100\/tsw.2002.81","journal-title":"ScientificWorldJournal"},{"key":"3599_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1442-9071.2012.02868.x","volume":"41","author":"JY Zhang","year":"2013","unstructured":"Zhang JY, Feng YF, Cai JQ (2013) Phacoemulsification versus manual small-incision cataract surgery for age-related cataract: meta-analysis of randomized controlled trials. Clin Exp Ophthalmol 41:379\u2013386. doi: 10.1111\/j.1442-9071.2012.02868.x","journal-title":"Clin Exp Ophthalmol"},{"key":"3599_CR46","doi-asserted-by":"publisher","first-page":"968.e33","DOI":"10.1016\/j.ajo.2015.07.032","volume":"160","author":"LH Wielders","year":"2015","unstructured":"Wielders LH, Lambermont VA, Schouten JS, van den Biggelaar FJ, Worthy G, Simons RW, Winkens B, Nuijts RM (2015) Prevention of cystoid macular edema after cataract surgery in nondiabetic and diabetic patients: a systematic review and meta-analysis. Am J Ophthalmol 160:968.e33\u2013981.e33. doi: 10.1016\/j.ajo.2015.07.032","journal-title":"Am J Ophthalmol"},{"key":"3599_CR47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/112067219700700204","volume":"7","author":"JJ Endt van","year":"1997","unstructured":"van Endt JJ, Veraart HG, Kramer R, Janssen AG, Sunder Raj P (1997) A comparison of two ophthalmic steroid-antibiotic combinations after cataract surgery. Eur J Ophthalmol 7:144\u2013148","journal-title":"Eur J Ophthalmol"},{"key":"3599_CR48","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ajo.2008.04.036","volume":"146","author":"JR Wittpenn","year":"2008","unstructured":"Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group (2008) A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol 146:554\u2013560. doi: 10.1016\/j.ajo.2008.04.036","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3599-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3599-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T21:54:15Z","timestamp":1568757255000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3599-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,27]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3599-8","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,27]]}}}